Clinical & Diagnostic

DetectedX and GE Healthcare Enter Mammography Education Partnership to Improve Accuracy and Better Inform Clinical Decisions

Fostering global excellence in diagnostic accuracy, DetectedX and GE Healthcare have entered into an educational partnership to expand access to the Radiol...

 April 26, 2022 | News

CMS is aimed at accelerating innovation incubation through models of industrial investment and customized development

Recently, China Medical System ("CMS", 0867.HK) announced its annual results. After recording continuous performance growth in the difficult time of the pa...

 April 18, 2022 | News

Telix Pharmaceuticals Announces Licence Agreement with Lilly for Olaratumab

 Telix Pharmaceuticals Limited (ASX: TLX, "Telix", the "Company") today announces that it has entered into a licence agreement with Eli Lilly and Comp...

 April 11, 2022 | News

FDA approves CartiHeal's Implant for the Treatment of Cartilage and Osteochondral Defects

 CartiHeal Ltd, developer of implants for the treatment of cartilage and osteochondral defects in arthritic and non-arthritic knee-joints, today annou...

 March 31, 2022 | News

BioVaxys Expands Cancer Vaccine Platform

BioVaxys Technology Corp. (CSE: BIOV), (FRA: 5LB), (OTCQB: BVAXF) ("BioVaxys" or "Company"), announced today the expansion of its cancer vaccine platf...

 March 31, 2022 | News

Telix and Xiel Sign U.K. and Ireland Distribution Agreement for Illuccix®

Under the terms of the agreement, Xiel, a specialist distributor of Nuclear Medicine, Radiotherapy and Diagnostic Radiology technologies across the U.K. an...

 March 29, 2022 | News

Innovent and Lilly Expand Strategic Partnership in Oncology

i) an agreement for Innovent to obtain the sole commercialization rights to import, market, promote, distribute and detail Cyramza® (ramucirumab) ...

 March 28, 2022 | News

Fujifilm to Acquire Shenandoah Biotechnology

Acquisition offers customers worldwide a single point of access for cGMP cell culture solutions for biopharmaceuticals, and cell and gene therapies FUJIFI...

 March 24, 2022 | News

CanSinoBIO's Convidecia™ Approved as Heterologous Booster in Malaysia and Indonesia

The MOH Malaysia recommends using Convidecia™ as a heterologous booster for individuals aged 18 and above who have been administered two doses of ina...

 March 23, 2022 | News

Telix Advances Development of Glioblastoma Therapy Program

TLX101 (4-L-[131I] iodo-phenylalanine, or 131I-IPA) is one of the Company's lead therapeutic clinical programs and has been granted orphan drug design...

 March 23, 2022 | News

Gene Solutions Makes Earlier Detection of Cancer A Possibility of the Future

Globally, cancer causes one in six deaths with more than 21 million people developing annually. 70% of cancers in patients are detected at late stages in w...

 March 16, 2022 | News

Baxter to tackle the growing burden of kidney disease in Asia Pacific

Baxter Asia Pacific (Baxter), a global leader in dialysis care, has launched the Know Your Score campaign across Asia Pacific (APAC) on...

 March 10, 2022 | News

Arctoris and Evariste Technologies form a Joint Venture to Identify Novel Small Molecule cMET Inhibitors for Non-Small Cell Lung Cancer

Arctoris, a tech-enabled biopharma company, and Evariste Technologies, an AI-drug discovery company, today announced they have formed a joint venture to id...

 March 08, 2022 | News

Malaysian-Made ProDetect(R) Rapid Test-Kit Scores 100% Accuracy in International Assessment

As the Omicron variant takes hold in Malaysia, the availability of high accuracy Antigen Test Kits is increasingly vital in the drive to identify infe...

 March 02, 2022 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close